Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2014 03:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Annual Report 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} The Board of Directors of PCI Biotech Holding ASA...
March 25, 2014 03:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Årsrapport 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Styret i PCI Biotech Holding ASA har godkjent...
February 25, 2014 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Resultatrapport for 4.kvartal 2013 og foreløpig resultat 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 25.februar 2014 Vedlagt er presentasjon...
February 25, 2014 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Fourth quarter 2013 and preliminary 2013 results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, Norway, 25 February 2014. Please find...
February 18, 2014 10:07 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Presentation of fourth quarter 2013 results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} (Lysaker, Norway, 18 February, 2014) PCI Biotech...
February 18, 2014 10:07 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Presentasjon av resultater for fjerde kvartal 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} (Lysaker, 18. februar 2014) PCI Biotech Holding...
February 04, 2014 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Første pasient behandlet i Amphinex-studien for pasienter med gallegangskreft

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 4. februar 2014 - PCI Biotech (PCIB)...
February 04, 2014 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: First patient treated in the study of Amphinex in patients with bile duct cancer (Cholangiocarcinoma)

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 4 February 2014 - PCI Biotech (PCIB) the...
January 30, 2014 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech awarded NOK 12.5 million from The Research Council of Norway to further development of PCI for use in vaccination

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 30 January 2014 - PCI Biotech (PCIB) the...
January 30, 2014 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech innvilget NOK 12,5 millioner fra Norges Forskningsråd til videreutvikling av PCI for vaksinering

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 30.januar 2014 - PCI Biotech (PCIB) melder...